Study Stopped
Insufficient research manpower
Imaging Enhanced Endoscopy for the Screening of Barrett's Esophagus
1 other identifier
observational
51
1 country
1
Brief Summary
Imaging enhanced endoscopy can improve the efficacy of screening of Barrett's esophagus and predict its invasiveness. There is potentially molecular change over the Barrett's esophagus in this Chinese population. To evaluate the efficacy of imaging enhanced endoscopy for screening of Barrett's esophagus and evaluation of invasiveness
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2010
CompletedFirst Submitted
Initial submission to the registry
October 23, 2013
CompletedFirst Posted
Study publicly available on registry
November 5, 2013
CompletedNovember 5, 2013
October 1, 2013
1.1 years
October 23, 2013
October 29, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The relationship between the mucosal morphology by imaging enhanced endoscopy and the presence of high-grade intraepithelial neoplasia from non-dysplastic specialized intestinal metaplasia.
Up to one month
Study Arms (1)
Barrett's esophagus
Patients were eligible for the study if they were scheduled for endoscopic examination at the National Taiwan University Hospital and its Yun-Lin branch, because of a BE, with or without a previous history of dysplasia. Exclusion criteria included patients who are younger than 20 years of age or patients with esophageal or cardiac varices or pregnant women.
Eligibility Criteria
Patients were eligible for the study if they were scheduled for endoscopic examination at the National Taiwan University Hospital and its Yun-Lin branch, because of a BE, with or without a previous history of dysplasia. Exclusion criteria included patients who are younger than 20 years of age or patients with esophageal or cardiac varices or pregnant women.
You may qualify if:
- suspected or a history of Barrett's esophagus for endoscopic exam
You may not qualify if:
- younger than 20 years of age
- patients with esophageal or cardiac varices
- pregnant women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, 100, Taiwan
Biospecimen
A standardized endoscopic biopsy protocol was performed at sites with ESEM which usually appeared as a reddish discoloration in an otherwise relatively whitish esophageal mucosa. Two pieces of specimen were taken; one for histological confirmation and another one (preserved as frozen tissue) for DNA analysis or immuno-histochemical staining. Biopsy from gastric cardia was also taken for histological confirmation.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yi-Chia Lee, MD,Msc
National Taiwan University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2013
First Posted
November 5, 2013
Study Start
September 1, 2009
Primary Completion
October 1, 2010
Study Completion
October 1, 2010
Last Updated
November 5, 2013
Record last verified: 2013-10